Royal Honor International Co., Ltd.
Update:2026/01/07
Industries
Main Industry
Media and Entertainment
Main Product/Service
GeneASIC NGSAAP
Next-Generation Sequencing Analysis Acceleration Platform
Ultra-fast NGS analysis on-premise solution. Deliver data center-grade performance in a compact form factor.
Learn More
Project XY: Genome Insights
Lifespan healthcare planning wi
Next-Generation Sequencing Analysis Acceleration Platform
Ultra-fast NGS analysis on-premise solution. Deliver data center-grade performance in a compact form factor.
Learn More
Project XY: Genome Insights
Lifespan healthcare planning wi
Founded Year
2019
Unified Business No.
50912093
Status
Active
Number of Employees
4
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taoyuan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Break down the barriers of sequencing technology
As scientists in the bioinformatics field, we saw how powerful genomics could be and the technical bottlenecks in introducing sequencing technology to the general public. We have the vision to promote genom
As scientists in the bioinformatics field, we saw how powerful genomics could be and the technical bottlenecks in introducing sequencing technology to the general public. We have the vision to promote genom